Anne Rufiange

641 total citations
11 papers, 509 citations indexed

About

Anne Rufiange is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Anne Rufiange has authored 11 papers receiving a total of 509 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 2 papers in Immunology and 2 papers in Cancer Research. Recurrent topics in Anne Rufiange's work include Genomics and Chromatin Dynamics (8 papers), RNA Research and Splicing (5 papers) and Fungal and yeast genetics research (4 papers). Anne Rufiange is often cited by papers focused on Genomics and Chromatin Dynamics (8 papers), RNA Research and Splicing (5 papers) and Fungal and yeast genetics research (4 papers). Anne Rufiange collaborates with scholars based in Canada, United States and Switzerland. Anne Rufiange's co-authors include Amine Nourani, Wajid Waheed Bhat, François Robert, Pierre‐Étienne Jacques, Éric R. Paquet, Joseph A. Martens, Andrea A. Duina, Fred Winston, John H. Bracey and Shoudeng Chen and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Genes & Development.

In The Last Decade

Anne Rufiange

10 papers receiving 505 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anne Rufiange Canada 9 482 80 28 25 18 11 509
Guifen Wu China 7 337 0.7× 38 0.5× 43 1.5× 21 0.8× 10 0.6× 12 379
Silvia Jimeno-González Spain 12 476 1.0× 35 0.4× 23 0.8× 26 1.0× 27 1.5× 18 516
Vanivilasini Balachandran United States 10 500 1.0× 109 1.4× 40 1.4× 22 0.9× 10 0.6× 13 524
Maria Anokhina Germany 8 669 1.4× 40 0.5× 34 1.2× 17 0.7× 7 0.4× 11 709
Christopher J. Wedeles Canada 7 252 0.5× 96 1.2× 29 1.0× 19 0.8× 12 0.7× 9 314
Michelle Wu United States 5 550 1.1× 157 2.0× 23 0.8× 38 1.5× 19 1.1× 10 594
Jothy Dhakshnamoorthy United States 13 765 1.6× 199 2.5× 50 1.8× 23 0.9× 13 0.7× 18 802
Shibin Hu China 8 383 0.8× 24 0.3× 35 1.3× 47 1.9× 37 2.1× 10 412
Olivia Mackenzie United States 4 131 0.3× 65 0.8× 29 1.0× 27 1.1× 9 0.5× 6 160
Katherine A. Braun United States 9 340 0.7× 53 0.7× 35 1.3× 53 2.1× 38 2.1× 10 373

Countries citing papers authored by Anne Rufiange

Since Specialization
Citations

This map shows the geographic impact of Anne Rufiange's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Rufiange with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Rufiange more than expected).

Fields of papers citing papers by Anne Rufiange

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Rufiange. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Rufiange. The network helps show where Anne Rufiange may publish in the future.

Co-authorship network of co-authors of Anne Rufiange

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Rufiange. A scholar is included among the top collaborators of Anne Rufiange based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Rufiange. Anne Rufiange is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Rufiange, Anne, et al.. (2023). Connectome and regulatory hubs of CAGE highly active enhancers. Scientific Reports. 13(1). 5594–5594.
2.
Chignon, Arnaud, Samuel Mathieu, Anne Rufiange, et al.. (2022). Enhancer promoter interactome and Mendelian randomization identify network of druggable vascular genes in coronary artery disease. Human Genomics. 16(1). 8–8. 6 indexed citations
3.
Chignon, Arnaud, Mickaël Rosa, Marie‐Chloé Boulanger, et al.. (2021). Enhancer-associated aortic valve stenosis risk locus 1p21.2 alters NFATC2 binding site and promotes fibrogenesis. iScience. 24(3). 102241–102241. 11 indexed citations
4.
Bhat, Wajid Waheed, et al.. (2018). Casein kinase 2 mediated phosphorylation of Spt6 modulates histone dynamics and regulates spurious transcription. Nucleic Acids Research. 46(15). 7612–7630. 22 indexed citations
5.
Chen, Shoudeng, Anne Rufiange, Hongda Huang, et al.. (2015). Structure–function studies of histone H3/H4 tetramer maintenance during transcription by chaperone Spt2. Genes & Development. 29(12). 1326–1340. 36 indexed citations
6.
Bhat, Wajid Waheed, et al.. (2013). Casein Kinase 2 Associates with the Yeast Chromatin Reassembly Factor Spt2/Sin1 To Regulate Its Function in the Repression of Spurious Transcription. Molecular and Cellular Biology. 33(21). 4198–4211. 11 indexed citations
7.
Bhat, Wajid Waheed, et al.. (2011). Transcription Regulation by the Noncoding RNA SRG1 Requires Spt2-Dependent Chromatin Deposition in the Wake of RNA Polymerase II. Molecular and Cellular Biology. 31(6). 1288–1300. 49 indexed citations
9.
Rufiange, Anne, Pierre‐Étienne Jacques, Wajid Waheed Bhat, François Robert, & Amine Nourani. (2007). Genome-Wide Replication-Independent Histone H3 Exchange Occurs Predominantly at Promoters and Implicates H3 K56 Acetylation and Asf1. Molecular Cell. 27(3). 393–405. 258 indexed citations
11.
Zaniolo, Karine, Anne Rufiange, Steeve Leclerc, Serge Desnoyers, & Sylvain L. Guérin. (2005). Regulation of the poly(ADP-ribose) polymerase-1 gene expression by the transcription factors Sp1 and Sp3 is under the influence of cell density in primary cultured cells. Biochemical Journal. 389(2). 423–433. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026